Angiotensin III activates NF-kappaB in mesangial cells primarily via AT2 receptors, highlighting a novel intracellular signaling mechanism for AT2 receptors in the kidney.
No takes yet. Share an insight, caveat, or question.
Does not inform clinical practice; leaves open differential AT2 roles in renal inflammation pending in vivo and human validation.
Lorenzo et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: